Herbalife Ltd. has announced plans to acquire selected assets from Bioniq. This strategic move aims to strengthen its position in the personalized nutrition market. The deal highlights Herbalife’s commitment to data-driven wellness solutions.
Herbalife is focusing on the future of personalized health. The company plans to combine Bioniq’s advanced supplement technology with its global distribution network. This integration will enable scalable and customized wellness solutions.
CEO Stephan Gratziani emphasized that data-driven health is the future. He stated that personalization will play a key role in improving wellness outcomes worldwide.
Bioniq specializes in creating personalized supplements. It uses health data, biomarkers, and lifestyle inputs. Its patented technology ensures tailored nutrition for each individual.
The company serves a wide audience. This includes everyday users and elite athletes like Cristiano Ronaldo. Its database-driven approach helps identify nutrient deficiencies and optimize health.
This acquisition builds on Herbalife’s previous investments. These include Pro2col and Link BioSciences. Together, they enhance Herbalife’s capabilities in personalized nutrition.
By combining these technologies, Herbalife can offer diverse supplement formats. It also improves speed and efficiency in product delivery at a global scale.
Vadim Fedotov shared his vision behind Bioniq. He highlighted the importance of science-based nutrition using biomarkers and lifestyle data.
He expressed excitement about joining Herbalife. The partnership will help expand access to personalized health solutions worldwide.
Cristiano Ronaldo has been a long-term partner of Herbalife. He is also a Bioniq shareholder. He strongly supports personalized nutrition and biometrics.
Ronaldo stated that tailored nutrition has helped him maintain peak performance. He believes this collaboration will make advanced nutrition accessible to more people.
The acquisition is expected to close in Q2 2026. It is subject to regulatory approvals and standard conditions.
Herbalife has also secured a call option for Bioniq LAB. This platform focuses on peptides and small molecules. It provides future growth opportunities.
Herbalife plans to launch Bioniq’s products later in 2026. The rollout will begin in Europe and the United States. Additional markets will follow gradually.
Products will be distributed through Herbalife’s independent distributors. This ensures global reach and personalized customer support.
Herbalife is a global health and wellness company. It operates in over 90 markets worldwide. The company provides science-backed nutrition products through its distributor network.
Bioniq was founded in 2019 in London. It focuses on personalized supplements using blood test data and questionnaires. The company has developed customized formulas for thousands of users globally.
This acquisition marks a major step in personalized nutrition. Herbalife is combining technology, data, and global reach. The goal is to make tailored wellness solutions accessible worldwide.
There are no reviews yet. Be the first one to write one.
